Targeting F box protein Fbxo3 to control cytokine-driven inflammation

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5247-5255

  Mallampalli, Rama K ^a,b,c   Coon, Tiffany A ^a,b   Glasser, Jennifer R ^a,b   Wang, Claire ^a,b   Dunn, Sarah R ^a,b   Weathington, Nathaniel M ^a,b   Zhao, Jing ^a,b   Zou, Chunbin ^a,b   Zhao, Yutong ^a,b   Chen, Bill B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; PROTEIN FBXO3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BC-1215; BENZYLAMINE DERIVATIVE; CYTOKINE; FBXL2 PROTEIN, MOUSE; FBXO3 PROTEIN, MOUSE; PYRIDINE DERIVATIVE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLITIS; CYTOKINE RELEASE; DISEASE CONTROL; INFLAMMATION; INFLAMMATORY CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; SEPTIC SHOCK; TISSUE INJURY; VIRUS PNEUMONIA; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; LUNG INJURY; METABOLISM; ORTHOMYXOVIRIDAE INFECTIONS; SECRETION (PROCESS); VIROLOGY;

ANIMALS; BENZYLAMINES; CELL LINE; COLITIS; CYTOKINES; F-BOX PROTEINS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; LEUKOCYTES, MONONUCLEAR; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PYRIDINES; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84887468994     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300456     Document Type: Article

References (49)

1. Sheu, C. C., M. N. Gong, R. Zhai, E. K. Bajwa, F. Chen, B. T. Thompson, and D. C. Christiani. 2010. The influence of infection sites on development and mortality of ARDS. Intensive Care Med. 36:963-970.
2. Dinarello, C. A. 2007. Historical insights into cytokines. Eur. J. Immunol. 37 (Suppl. 1):S34-S45.
3. Annane, D., and J. M. Cavaillon. 2003. Corticosteroids in sepsis: from bench to bedside? Shock 20:197-207.
4. Sweeney, D. A., R. L. Danner, P. Q. Eichacker, and C. Natanson. 2008. Once is not enough: clinical trials in sepsis. Intensive Care Med. 34:1955-1960.
5. Angus, D. C. 2011. The search for effective therapy for sepsis: back to the drawing board? JAMA 306:2614-2615.
6. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9:517-524.
7. Paterson, R. L., H. F. Galley, and N. R. Webster. 2003. The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit. Care Med. 31:2574-2578.
8. Inoue, Ji., T. Ishida, N. Tsukamoto, N. Kobayashi, A. Naito, S. Azuma, and T. Yamamoto. 2000. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254:14-24.
9. Xu, L. G., L. Y. Li, and H. B. Shu. 2004. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J. Biol. Chem. 279:17278-17282.
10. Rickert, R. C., J. Jellusova, and A. V. Miletic. 2011. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol. Rev. 244:115-133.
11. London, N. R., W. Zhu, F. A. Bozza, M. C. Smith, D. M. Greif, L. K. Sorensen, L. Chen, Y. Kaminoh, A. C. Chan, S. F. Passi, et al. 2010. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2:23ra19.
12. Harrison, C. 2010. Sepsis: calming the cytokine storm. Nat. Rev. Drug Discov. 9:360-361.
13. Tanaka, Y., N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii, and K. Sugamura. 2008. c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 28:4805-4818.
14. Hochstrasser, M. 2000. Biochemistry. All in the ubiquitin family. Science 289:563-564.
15. Jin, J., T. Cardozo, R. C. Lovering, S. J. Elledge, M. Pagano, and J. W. Harper. 2004. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18:2573-2580.
16. Chen, B. B., T. A. Coon, J. R. Glasser, and R. K. Mallampalli. 2011. Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis. Mol. Cell. Biol. 31:1905-1920.
17. Chen, B. B., J. R. Glasser, T. A. Coon, C. Zou, H. L. Miller, M. Fenton, J. F. McDyer, M. Boyiadzis, and R. K. Mallampalli. 2012. F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood 119:3132-3141.
18. Chen, B. B., T. A. Coon, J. R. Glasser, B. J. McVerry, J. Zhao, Y. Zhao, C. Zou, B. Ellis, F. C. Sciurba, Y. Zhang, and R. K. Mallampalli. 2013. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat. Immunol. 14:470-479.
19. Ray, N. B., L. Durairaj, B. B. Chen, B. J. McVerry, A. J. Ryan, M. Donahoe, A. K. Waltenbaugh, C. P. O'Donnell, F. C. Henderson, C. A. Etscheidt, et al. 2010. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat. Med. 16:1120-1127.
20. Chen, B. B., and R. K. Mallampalli. 2007. Calmodulin binds and stabilizes the regulatory enzyme, CTP: phosphocholine cytidylyltransferase. J. Biol. Chem. 282:33494-33506.
21. Chen, B. B., J. R. Glasser, T. A. Coon, and R. K. Mallampalli. 2012. F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitinmediated degradation of cyclin D3 resulting in cell cycle arrest. Oncogene 31:2566-2579.
22. Butler, P. L., and R. K. Mallampalli. 2010. Cross-talk between remodeling and de novo pathways maintains phospholipid balance through ubiquitination. J. Biol. Chem. 285:6246-6258.
23. Posadas, I., M. Bucci, F. Roviezzo, A. Rossi, L. Parente, L. Sautebin, and G. Cirino. 2004. Carrageenan-induced mouse paw oedema is biphasic, ageweight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br. J. Pharmacol. 142:331-338.
24. Yoshihara, K., T. Yajima, C. Kubo, and Y. Yoshikai. 2006. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 55:334-341.
25. Katsuyama, A. M., D. O. Cicero, A. Spisni, M. Paci, C. S. Farah, and T. A. Pertinhez. 2004. 1H, 15N and 13C resonance assignments of the ApaG protein of the phytopathogen Xanthomonas axonopodis pv. citri. J. Biomol. NMR 29:423-424.
26. Winston, J. T., D. M. Koepp, C. Zhu, S. J. Elledge, and J. W. Harper. 1999. A family of mammalian F-box proteins. Curr. Biol. 9:1180-1182.
27. Wu, S., and Y. Zhang. 2007. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res. 35:3375-3382.
28. Bralley, E. E., P. Greenspan, J. L. Hargrove, L. Wicker, and D. K. Hartle. 2008. Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J. Inflamm. 5:1.
29. Claes, C., W. Kulp, W. Greiner, J. M. Von Der Schulenburg, and T. Werfel. 2006. Therapy of moderate and severe psoriasis. GMS Health Technol. Assess. 2: Doc07.
30. De Quervain, D. J. 2006. Glucocorticoid-induced inhibition of memory retrieval: implications for posttraumatic stress disorder. Ann. N. Y. Acad. Sci. 1071:216-220.
31. Foster, J. M., E. Van Sonderen, A. J. Lee, R. Sanderman, A. Dijkstra, D. S. Postma, and T. Van Der Molen. 2006. A self-rating scale for patientperceived side effects of inhaled corticosteroids. Respir. Res. 7:131.
32. Hansen, G., T. R. Hercus, B. J. McClure, F. C. Stomski, M. Dottore, J. Powell, H. Ramshaw, J. M. Woodcock, Y. Xu, M. Guthridge, et al. 2008. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134:496-507.
33. Zaghi, D., G. G. Krueger, and K. Callis Duffin. 2012. Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis. J. Drugs Dermatol. 11:160-167.
34. Herrlinger, K., and E. F. Stange. 2008. [Inflammatory bowel diseases-new therapeutic options]. Med. Klin. 103:90-101, quiz 102-103.
35. Mahadevan, U. 2007. TNF-a antagonists: benefits beyond remission. Rev. Gastroenterol. Disord. 7 (Suppl. 1):S13-S19.
36. Murdaca, G., B. M. Colombo, and F. Puppo. 2011. Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications. Drugs Today 47:277-288.
37. Launois, R., B. Avouac, F. Berenbaum, O. Blin, I. Bru, B. Fautrel, J. M. Joubert, J. Sibilia, and B. Combe. 2011. Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis. J. Rheumatol. 38:835-845.
38. Laurance, B. 1954. Penicillin by mouth in infancy; a comparison between benzathine and sodium penicillins. BMJ 2:1392-1394.
39. Anderson, H. C. 1954. Prolonged reaction to intramuscular benzathine penicillin. Lancet 267:1157-1158.
40. 1954. Report on benzathine penicillin G. J. Am. Dent. Assoc. 49:714-715.
41. Chin, K. H., C. C. Chou, C. C. Lee, H. L. Shr, P. C. Lyu, A. H. Wang, and S. H. Chou. 2005. Preparation, crystallization and preliminary X-ray analysis of XC2382, an ApaG protein of unknown structure from Xanthomonas campestris. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61:700-702.
42. Ilyin, G. P., M. Rialland, C. Pigeon, and C. Guguen-Guillouzo. 2000. cDNA cloning and expression analysis of new members of the mammalian F-box protein family. Genomics 67:40-47.
43. Liu, L., E. M. Rodriguez-Belmonte, N. Mazloum, B. Xie, and M. Y. Lee. 2003. Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen. J. Biol. Chem. 278:10041-10047.
44. Wang, J., M. P. Nikrad, E. A. Travanty, B. Zhou, T. Phang, B. Gao, T. Alford, Y. Ito, P. Nahreini, K. Hartshorn, et al. 2012. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One 7:e29879.
45. Rath, H. C., M. Schultz, R. Freitag, L. A. Dieleman, F. Li, H. J. Linde, J. Schölmerich, and R. B. Sartor. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69:2277-2285.
46. Rocha, A. C., E. S. Fernandes, N. L. Quintão, M. M. Campos, and J. B. Calixto. 2006. Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br. J. Pharmacol. 148:688-695.
47. Krieglstein, C. F., W. H. Cerwinka, A. G. Sprague, F. S. Laroux, M. B. Grisham, V. E. Koteliansky, N. Senninger, D. N. Granger, and A. R. De Fougerolles. 2002. Collagen-binding integrin a1b1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110:1773-1782.
48. Yoon, T., Y. Lee, A. Y. Lee, G. Choi, B. K. Choo, and H. K. Kim. 2010. Antiinflammatory effects of Glehnia littoralis extract in acute and chronic cutaneous inflammation. Immunopharmacol. Immunotoxicol. 32:663-670.
49. Masuda, K., R. Masuda, M. Neidhart, B. R. Simmen, B. A. Michel, U. Müller-Ladner, R. E. Gay, and S. Gay. 2002. Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res. 4:R8.